Page 1 of Clinical Trials for "Granuloma, Plasma Cell", 2 Total Matches

  • …
  • Tell a FriendPrint
  • 1
    Not yet recruiting
    CREATE: Cross-tumoral Phase 2 With Crizotinib
    Last Updated: January 31, 2012
    Condition(s): Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma; Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor; Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1; Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma; Locally Advanced and/or Metastatic Clear Cell Sarcoma; Locally Advanced and/or Metastatic Alveolar Rhabdomyosarcoma
  • 2
    Recruiting
    A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
    Last Updated: April 10, 2012
    Condition(s): Advanced Malignancies; Carcinoma, Non-Small-Cell Lung; Anaplastic Large Cell Lymphoma; Diffuse Large Cell Lymphoma; Inflammatory Myofibroblastic Tumors
  • …
  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Granuloma%2C+Plasma+Cell%22